ArticleDrug safety2026

Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in US Medicare Adults Age 65 Years or Older.

Susan Dos Reis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.